Clinical Trials on Type 2 Bipolar Disorder in Czechia

Total 733 results

Charles University, Czech Republic

Recruiting

Pulse Width 0.15ms vs 0.30ms in Electroconvulsive Therapy (PWECT015)

Bipolar Depression | Major Depressive Disorder

Czechia
National Institute of Mental Health, Czech Republic
Mindpax s.r.o., Czech Republic

Active, not recruiting

AKTIBIPO-VALIDATION: A Study to Validate Benefits of Mindpax System in Managing Bipolar Disorder (VAL1M)

Bipolar Disorder

Czechia
Institute for Clinical and Experimental Medicine

Completed

Processed Meat and Brain Regions Related to Reward and Addiction (RewCrav)

Type 2 Diabetes

Czechia
Charles University, Czech Republic

Completed

Adipose Tissue Expandability and Type 2 Diabetes (LIMEX)

Type2 Diabetes Mellitus

Czechia
University of Ostrava
Institute for Clinical and Experimental Medicine; Vitkovice Hospital

Active, not recruiting

Small Bowel Diversion

Obesity | Type2 Diabetes

Czechia
University Hospital Ostrava
Ministry of Health, Czech Republic; Regional Council of the Moravian-Silesian...

Completed

Safety and Efficacy Study of Autologous Bone Marrow Aspirate Concentrate for No-Option Critical Limb Ischemia (DIALEG)

Critical Lower Limb Ischemia | Type-2 Diabetes Mellitus

Czechia
Institute for Clinical and Experimental Medicine

Unknown

Compliance of Diabetic Patients Treated With Metformin (CODAMET)

Type 2 Diabetes Mellitus

Czechia
Charles University, Czech Republic

Completed

Safety Evaluation of Adverse Reactions in Diabetes (SAFEGUARD)

Type 2 Diabetes Mellitus

Czechia
GT Metabolic Solutions, Inc.

Recruiting

Magnetic Jejuno-Ileal Diversion Study ("MJI Study")

Obesity | Type 2 Diabetes

Czechia
Charles University, Czech Republic
University Ghent; University of Leicester; St George's, University of London; University...

Recruiting

mHealth Intervention to Increase Physical Activity in Prediabetes and Type 2 Diabetes (ENERGISED)

PreDiabetes | Type 2 Diabetes

Czechia
Sanofi

Completed

SOLMANIA - Comparison of Valproate-Amisulpride and Valproate-Haloperidol in Bipolar I Patients

Bipolar Disorder

France, Spain, Poland, Czech Republic, Slovakia
University Hospital Ostrava
University of Ostrava; Vitkovice Hospital, Ostrava, Czech Republic

Completed

Metabolic Changes After Bariatric Surgery

Type 2 Diabetes Mellitus | Grade III Obesity

Czechia
Institute for Clinical and Experimental Medicine

Unknown

The Role of Insulin Resistance in Patients With Heart Failure and Type 2 Diabetes (CARMET2)

Insulin Resistance | Chronic Heart Failure

Czechia
Sunovion

Completed

Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)

Bipolar Depression

United States, Czech Republic, India, France, Germany, Poland, Romania, Russian Federation, South Africa, Ukraine
Institute for Clinical and Experimental Medicine

Recruiting

INSULIN THERAPY DE-INTENSIFICATION WITH iGlarLixi (IDEAL)

Type 2 Diabetes Treated With Insulin

Czechia
Sunovion

Completed

Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Monotherapy)

Bipolar Depression

United States, Czech Republic, India, France, Romania, Russian Federation, South Africa, Ukraine
Charles University, Czech Republic

Completed

Effect of Metformin on Exercise-induced Lipolysis

Diabetes Mellitus, Type 2

Czechia
Sunovion

Completed

Lurasidone HCI - A 6-week Phase 3 Study of Patients With Bipolar I Depression (PREVAIL3)

Bipolar Depression

United States, Canada, Colombia, Czech Republic, India, Japan, Lithuania, Peru, Slovakia, Ukraine
Sunovion

Completed

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

Bipolar Depression

United States, Canada, Czech Republic, India, Lithuania, Peru, South Africa, France, Poland, Romania, Russian Federation, Ukraine, Colombia, Slovakia, Japan
Vitadio s.r.o.
University Hospital Olomouc

Completed

Impact of Digital Therapeutic on Metabolic Parameters

Obesity | Diabetes Mellitus, Type 2 | Insulin Resistance | Prediabetic State

Czechia
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Study to Evaluate the Efficacy and Safety of Aripiprazole Administered With Lithium or Valproate Over 12 Weeks in the Treatment of Mania in Bipolar I Disorder

Bipolar Disorder Mania

Italy, Poland, Russian Federation, Turkey, South Africa, Austria, Hungary, France, Spain, Czech Republic, Germany, Greece, Romania
Astellas Pharma Inc

Completed

Renal Impairment Study With ASP1941

Type 2 Diabetes Mellitus

Hungary, Poland, Czechia, Slovakia
University Hospital, Montpellier

Completed

Personalized Glucose Predictive and Therapy Advisory System - DIAdvisor 2

Diabetes Mellitus, Type 2 | Diabetes Mellitus | Diabetes Mellitus, Type 1

France, Italy, Czechia
Novo Nordisk A/S

Completed

A Study to Test How a New Long-acting Insulin (Insulin Icodec) Works in the Body of People With Liver Disease

Diabetes Mellitus, Type 2

Slovakia, Czechia
Charles University, Czech Republic

Unknown

Is Real-time CGM Superior to Flash Glucose Monitoring (CORRIDA)

Diabetes Mellitus, Type 1

Czechia
Institute for Clinical and Experimental Medicine

Completed

Postprandial Insulin Secretion, Oxidative Stress and Gastrointestinal Peptides in Patients With Type 2 Diabetes Versus Healthy Subjects

Type 2 Diabetes | Postprandial Oxidative Stress

Czech Republic
Takeda

Terminated

Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder

Bipolar Disorder

United States, Ukraine, United Kingdom, Germany, Bulgaria, Romania, Serbia, Russian Federation, Czech Republic, Poland
Sunovion

Completed

Lurasidone Extended Use Study

Schizophrenia | Bipolar Disorder

Canada, Serbia, Colombia, Czech Republic, India, Lithuania, Slovakia, Ukraine, France, Romania, South Africa, Russian Federation
Charles University, Czech Republic

Completed

Effects of Chronic Dietary Exposure to Branched Chain Amino Acids

Type 2 Diabetes Mellitus With Features of Insulin Resistance

Czech Republic
Institute for Clinical and Experimental Medicine

Completed

Endothelial Function in Patients With Type 2 Diabetes Versus Healthy Subjects (EndoPat)

Insulin Resistance | Type 2 Diabetes

Czech Republic
Institute for Clinical and Experimental Medicine
Ministry of Health, Czech Republic

Completed

Effect of Angiotensin Receptor Blockade on Insulin Resistance and Adipose Tissue Cytokines in Type 2 Diabetes

Insulin Resistance | Type 2 Diabetes

Czech Republic
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

A Study of Aripiprazole (Abilify) in Patients With Bipolar Mania

Bipolar Disorder

United States, South Africa, Brazil, Russian Federation, France, Czechia, Croatia, India, Bulgaria
Digma Medical Ltd.

Recruiting

Safety and Initial Performance of the DiaGone Device on Type 2 Diabetes Patients

Diabetes Mellitus, Type 2

Israel, Czechia, Spain
KeyBioscience AG
Nordic Bioscience A/S

Completed

Study to Evaluate the Efficacy and Safety of KBP-042 in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Denmark, Czechia, Poland, Moldova, Republic of, Romania, United Kingdom
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Study of Aripiprazole in Patients With Bipolar I Disorder

Bipolar Disorder

France, Portugal, Spain, Italy, Germany, South Africa, United Kingdom, United States, Russian Federation, Poland, Czech Republic, Hungary, Netherlands, Estonia, Australia, Bulgaria, Switzerland
AGC Biologics S.p.A.
Horizon 2020 - European Commission

Terminated

Study of CAR T-cell Therapy in Acute Myeloid Leukemia and Multiple Myeloma

Acute Myeloid Leukemia | Multiple Myeloma

Italy, Czechia
Theracos

Completed

Safety and Efficacy of Bexagliflozin Compared to Sitagliptin as Add-on Therapy to Metformin in Type 2 Diabetes Subjects

Type 2 Diabetes Mellitus

United States, Japan, Czechia, Hungary, Poland, Spain
Novo Nordisk A/S

Completed

Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Hepatic Impairment

Healthy | Diabetes Mellitus, Type 2 | Diabetes

Poland, Slovakia, Czechia
University Hospital Ostrava

Completed

Recurrent Respiratory Papillomatosis and Extraesophageal Reflux

Recurrent Respiratory Papillomatosis | Extra Oesophageal Reflux | Laryngeal Cyst

Czechia
AstraZeneca

Completed

A 24-week Open-Label, Phase 3b Trial With a 28-week Extension to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin Compared to Insulin Glargine in Subjects withType 2 Diabetes Who Have Glycemic Control on Metformin

Type 2 Diabetes Mellitus

United States, Poland, Mexico, Hungary, Spain, Romania, South Africa, Denmark, Czechia, Sweden
ChemoCentryx

Completed

A Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Germany, New Zealand, Hungary, Czechia, Australia
Novartis

Completed

Open Label Extension Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder

Bipolar Disorder

Austria, Canada, Czech Republic, Germany, Peru, Russian Federation, Slovakia, South Africa, Ukraine, Venezuela, United States, Colombia, Guatemala
Institute for Clinical and Experimental Medicine
Poliklinika Agel, Dopravni zdravotnictvi a.s.

Recruiting

Gastric Pathophysiology in Diabetes (DiaFLIP)

Healthy | Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | Functional Dyspepsia | Gastroparesis

Czechia, Slovakia
AstraZeneca
Bristol-Myers Squibb

Completed

Evaluation of the Effect of Dapagliflozin in Combination With Metformin on Body Weight in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus

Sweden, Bulgaria, Czech Republic, Hungary, Poland
Novartis Pharmaceuticals

Completed

Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder

Bipolar Disorder

United States, Austria, Canada, Colombia, Czech Republic, Germany, Guatemala, Peru, Russian Federation, Slovakia, South Africa, Ukraine, Venezuela
Novo Nordisk A/S

Completed

Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Various Degrees of Impaired Renal Function

Healthy | Diabetes Mellitus, Type 2 | Diabetes

Hungary, Czechia
Eli Lilly and Company

Completed

A Study of LY2409021 on Blood Pressure and Pulse Rate in Participants With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

United States, Czechia, Puerto Rico, Poland, Mexico
Sanofi

Completed

Comparison Safety and Efficacy of Basal Insulin Lantus® (Insulin Glargine) vs NPH Insulin in Combination With Oral Antidiabetic Drugs (OADs) in Patients With Diabetes Mellitus, Type 2 (DMT2) (COBIN 2)

Diabetes Mellitus, Type 2

Czech Republic
Sunovion

Completed

This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296 (PERSISTExt)

Bipolar I Disorder

United States, Poland, Bulgaria, Japan, Slovakia, Hungary, Russian Federation, Czech Republic, Argentina, Chile, France, Serbia
Novo Nordisk A/S

Completed

Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern Insulin

Diabetes Mellitus, Type 2 | Diabetes

Czech Republic

Clinical Trials on Type 2 Bipolar Disorder in Czechia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Colombia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations